Dolby Laboratories, Inc. (DLB)
NYSE: DLB · Real-Time Price · USD
55.33
+0.56 (1.02%)
Nov 20, 2026, 4:00 PM EST - Market closed
Dolby Laboratories Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Sep '26 Sep 25, 2026 | Sep '25 Sep 26, 2025 | Sep '24 Sep 27, 2024 | Sep '23 Sep 29, 2023 | Sep '22 Sep 30, 2022 |
| 5,130 | 5,485 | 6,938 | 7,209 | 7,581 | 6,364 | |
Market Cap Growth | -17.36% | -20.94% | -3.76% | -4.90% | 19.12% | -32.12% |
Enterprise Value | 4,553 | 4,872 | 6,287 | 6,403 | 6,758 | 5,412 |
Last Close Price | 55.33 | 58.56 | 70.75 | 72.66 | 75.03 | 60.83 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Sep '26 Sep 25, 2026 | Sep '25 Sep 26, 2025 | Sep '24 Sep 27, 2024 | Sep '23 Sep 29, 2023 | Sep '22 Sep 30, 2022 |
PE Ratio | 20.49 | 21.28 | 27.21 | 27.54 | 37.78 | 34.57 |
Forward PE | 12.73 | 12.91 | 18.11 | 20.55 | 22.19 | 17.34 |
PS Ratio | 3.61 | 3.86 | 5.14 | 5.66 | 5.83 | 5.08 |
PB Ratio | 1.97 | 2.10 | 2.64 | 2.90 | 3.20 | 2.83 |
P/TBV Ratio | 3.04 | 3.26 | 4.09 | 4.78 | 4.26 | 3.60 |
P/FCF Ratio | 14.25 | 15.24 | 15.92 | 24.25 | 22.51 | 23.51 |
P/OCF Ratio | 12.84 | 13.73 | 14.69 | 22.03 | 20.65 | 19.98 |
PEG Ratio | - | 1.09 | 1.09 | 1.09 | 1.09 | 1.08 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Sep '26 Sep 25, 2026 | Sep '25 Sep 26, 2025 | Sep '24 Sep 27, 2024 | Sep '23 Sep 29, 2023 | Sep '22 Sep 30, 2022 |
EV/Sales Ratio | 3.20 | 3.43 | 4.66 | 5.03 | 5.20 | 4.32 |
EV/EBITDA Ratio | 10.97 | 11.74 | 17.10 | 18.47 | 19.57 | 17.70 |
EV/EBIT Ratio | 14.23 | 15.23 | 22.46 | 23.62 | 25.71 | 24.91 |
EV/FCF Ratio | 12.65 | 13.54 | 14.43 | 21.54 | 20.07 | 20.00 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Sep '26 Sep 25, 2026 | Sep '25 Sep 26, 2025 | Sep '24 Sep 27, 2024 | Sep '23 Sep 29, 2023 | Sep '22 Sep 30, 2022 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Debt / EBITDA Ratio | 0.11 | 0.11 | 0.10 | 0.13 | 0.14 | 0.16 |
Debt / FCF Ratio | 0.13 | 0.13 | 0.09 | 0.16 | 0.15 | 0.19 |
Net Debt / Equity Ratio | -0.22 | -0.22 | -0.25 | -0.17 | -0.35 | -0.34 |
Net Debt / EBITDA Ratio | -1.39 | -1.39 | -1.80 | -1.25 | -2.41 | -2.48 |
Net Debt / FCF Ratio | -1.60 | -1.60 | -1.52 | -1.46 | -2.48 | -2.80 |
Asset Turnover | 0.44 | 0.44 | 0.43 | 0.42 | 0.46 | 0.43 |
Inventory Turnover | 6.34 | 6.34 | 4.99 | 4.05 | 5.16 | 8.19 |
Quick Ratio | 2.77 | 2.77 | 2.77 | 2.38 | 3.15 | 4.43 |
Current Ratio | 3.18 | 3.18 | 3.17 | 2.86 | 3.52 | 4.72 |
Return on Equity (ROE) | 9.90% | 9.90% | 10.02% | 10.88% | 8.72% | 7.58% |
Return on Assets (ROA) | 8.06% | 8.06% | 8.05% | 8.60% | 7.08% | 6.35% |
Return on Invested Capital (ROIC) | 12.30% | 12.30% | 11.77% | 12.78% | 13.98% | 12.78% |
Return on Capital Employed (ROCE) | 11.60% | 11.60% | 10.00% | 10.10% | 10.30% | 9.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Sep '26 Sep 25, 2026 | Sep '25 Sep 26, 2025 | Sep '24 Sep 27, 2024 | Sep '23 Sep 29, 2023 | Sep '22 Sep 30, 2022 |
Earnings Yield | 4.88% | 4.70% | 3.68% | 3.63% | 2.65% | 2.89% |
FCF Yield | 7.02% | 6.56% | 6.28% | 4.12% | 4.44% | 4.25% |
Dividend Yield | 2.82% | 2.48% | 1.86% | 1.63% | 1.40% | 1.54% |
Payout Ratio | 57.78% | 52.89% | 49.64% | 43.76% | 51.53% | 54.36% |
Buyback Yield / Dilution | 1.94% | 1.94% | -0.16% | 0.42% | 4.17% | 2.52% |
Total Shareholder Return | 4.76% | 4.42% | 1.70% | 2.04% | 5.57% | 4.06% |